Elinx Stock

Elinx ROCE

The Return on Capital Employed (ROCE) of Elinx (ELNX) as of Aug 12, 2026 is 17.34 %.

ROCE

17.34 %

Last updated:

In 2026, Elinx's return on capital employed (ROCE) was 17.34 %, a % increase from the - ROCE in the previous year.

Access this data via the Eulerpool API

Elinx Stock analysis

What does Elinx do? Aperture Health Inc. is a globally operating company in the healthcare industry based in San Francisco, California. The company was founded in 2014 by a group of healthcare experts with the goal of revolutionizing healthcare. Since its inception, the company has experienced rapid growth and is now a major player in the healthcare market. Aperture Health Inc.'s business model is based on the development and sale of innovative products and services in the healthcare sector. The company operates in multiple business fields, all aiming to improve healthcare. This includes digital health, clinical diagnostic tests, healthcare, and health insurance. In the field of digital health, the company offers a wide range of solutions aimed at simplifying healthcare management. These solutions include mobile health applications that allow users to monitor and track their health data. The company is also working on the development of personalized medical devices and wearables that help diagnose and treat various health issues. Aperture Health Inc. is also involved in the development and manufacturing of clinical diagnostic tests. The company has developed a wide range of diagnostic tests for diseases such as cancer, diabetes, and HIV. These tests are fast and easy to perform and provide accurate results. In the area of healthcare, the company provides a wide range of services aimed at improving the quality of healthcare. These services include access to specialized medical professionals, assistance in organizing doctor visits, and prescription of medications. Aperture Health Inc. works closely with hospitals and medical facilities to provide seamless and high-quality healthcare. Aperture Health Inc. also offers innovative health insurance tailored to the needs of customers. These insurances combine a wide range of health insurance options that meet the customers' needs with an intelligent health management system that allows policyholders to monitor and improve their health. The company is also engaged in research and development of new treatment methods. Aperture Health Inc. collaborates closely with medical research institutions and professionals to develop new and innovative treatment methods that aim to improve healthcare globally. In summary, Aperture Health Inc. is a company that aims to revolutionize healthcare worldwide. The company offers innovative products and services aimed at improving people's health and increasing their quality of life. With a wide range of solutions in various business fields, Aperture Health Inc. has become a major player in the healthcare industry and will continue to play an important role in the future. Elinx is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Elinx's Return on Capital Employed (ROCE)

Elinx's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Elinx's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Elinx's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Elinx’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Elinx stock

Return on Capital Employed (ROCE) of Elinx is 17.34 % in 2026.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Elinx since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Elinx with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

Profitability — Elinx

All Key Metrics — Elinx